213 related articles for article (PubMed ID: 19422384)
1. Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage.
Moroni F; Formentini L; Gerace E; Camaioni E; Pellegrini-Giampietro DE; Chiarugi A; Pellicciari R
Br J Pharmacol; 2009 Jul; 157(5):854-62. PubMed ID: 19422384
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.
Moroni F; Meli E; Peruginelli F; Chiarugi A; Cozzi A; Picca R; Romagnoli P; Pellicciari R; Pellegrini-Giampietro DE
Cell Death Differ; 2001 Sep; 8(9):921-32. PubMed ID: 11526447
[TBL] [Abstract][Full Text] [Related]
3. Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance.
Gerace E; Scartabelli T; Formentini L; Landucci E; Moroni F; Chiarugi A; Pellegrini-Giampietro DE
Eur J Neurosci; 2012 Jul; 36(1):1993-2005. PubMed ID: 22639866
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage.
Meli E; Pangallo M; Baronti R; Chiarugi A; Cozzi A; Pellegrini-Giampietro DE; Moroni F
Toxicol Lett; 2003 Apr; 139(2-3):153-62. PubMed ID: 12628750
[TBL] [Abstract][Full Text] [Related]
5. PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptors.
Gerace E; Masi A; Resta F; Felici R; Landucci E; Mello T; Pellegrini-Giampietro DE; Mannaioni G; Moroni F
Neurobiol Dis; 2014 Oct; 70():43-52. PubMed ID: 24954469
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
Carpenedo R; Meli E; Peruginelli F; Pellegrini-Giampietro DE; Moroni F
J Neurochem; 2002 Sep; 82(6):1465-71. PubMed ID: 12354294
[TBL] [Abstract][Full Text] [Related]
7. The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.
Pugliese AM; Traini C; Cipriani S; Gianfriddo M; Mello T; Giovannini MG; Galli A; Pedata F
Br J Pharmacol; 2009 Jul; 157(5):818-30. PubMed ID: 19422385
[TBL] [Abstract][Full Text] [Related]
8. Features of the cytoprotective effect of selenium nanoparticles on primary cortical neurons and astrocytes during oxygen-glucose deprivation and reoxygenation.
Turovsky EA; Mal'tseva VN; Sarimov RM; Simakin AV; Gudkov SV; Plotnikov EY
Sci Rep; 2022 Feb; 12(1):1710. PubMed ID: 35110605
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial impairment induced by poly(ADP-ribose) polymerase-1 activation in cortical neurons after oxygen and glucose deprivation.
Tanaka S; Takehashi M; Iida S; Kitajima T; Kamanaka Y; Stedeford T; Banasik M; Ueda K
J Neurochem; 2005 Oct; 95(1):179-90. PubMed ID: 16181422
[TBL] [Abstract][Full Text] [Related]
10. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
11. The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia.
Plaschke K; Kopitz J; Weigand MA; Martin E; Bardenheuer HJ
Neurosci Lett; 2000 Apr; 284(1-2):109-12. PubMed ID: 10771174
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of a novel poly (ADP-ribose) polymerase-1 inhibitor, JPI-289, in hypoxic rat cortical neurons.
Kim Y; Kim YS; Noh MY; Lee H; Joe B; Kim HY; Kim J; Kim SH; Park J
Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):671-679. PubMed ID: 28370165
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca(2+) Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
Gerace E; Pellegrini-Giampietro DE; Moroni F; Mannaioni G
CNS Neurol Disord Drug Targets; 2015; 14(5):636-46. PubMed ID: 25924998
[TBL] [Abstract][Full Text] [Related]
15. Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage.
Moroni F; Carpenedo R; Cozzi A; Meli E; Chiarugi A; Pellegrini-Giampietro DE
Adv Exp Med Biol; 2003; 527():127-36. PubMed ID: 15206725
[TBL] [Abstract][Full Text] [Related]
16. Interplay between histone acetylation/deacetylation and poly(ADP-ribosyl)ation in the development of ischemic tolerance in vitro.
Gerace E; Landucci E; Scartabelli T; Moroni F; Chiarugi A; Pellegrini-Giampietro DE
Neuropharmacology; 2015 May; 92():125-34. PubMed ID: 25623965
[TBL] [Abstract][Full Text] [Related]
17. β-Adrenoceptor activation depresses brain inflammation and is neuroprotective in lipopolysaccharide-induced sensitization to oxygen-glucose deprivation in organotypic hippocampal slices.
Markus T; Hansson SR; Cronberg T; Cilio C; Wieloch T; Ley D
J Neuroinflammation; 2010 Dec; 7():94. PubMed ID: 21172031
[TBL] [Abstract][Full Text] [Related]
18. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.
Nakajima H; Kakui N; Ohkuma K; Ishikawa M; Hasegawa T
J Pharmacol Exp Ther; 2005 Feb; 312(2):472-81. PubMed ID: 15466246
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase.
Moroni F; Cozzi A; Chiarugi A; Formentini L; Camaioni E; Pellegrini-Giampietro DE; Chen Y; Liang S; Zaleska MM; Gonzales C; Wood A; Pellicciari R
Br J Pharmacol; 2012 Mar; 165(5):1487-500. PubMed ID: 21913897
[TBL] [Abstract][Full Text] [Related]
20. Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegeneration.
Harms C; Lautenschlager M; Bergk A; Katchanov J; Freyer D; Kapinya K; Herwig U; Megow D; Dirnagl U; Weber JR; Hörtnagl H
J Neurosci; 2001 Apr; 21(8):2600-9. PubMed ID: 11306613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
